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D95841 Prolonged Exposure of Csnine Coronsry Arteries
tos Nitric Oxide Donor Desensitizes Soiuble
Gusnylete Cyclese
D.G. Cable, P.Sorajja,H.V. Schaff. Mayo Clinic, l?dresteL MN, USA
Tolerance to nitric oxide donore is postulated to result from either substrate
limits on biodegradation ordesensitization ’of solubie guanylate cyclase. The
former is well characterized while the latter Is controversial. Paired canine
coronaries were exposed to either sodium nitroprusside (SNP) or pspaverine
in vaiying doses (10-9, 10-7, 10-5 M)for3 hrwithcontinuous recordingof iso-
matric tenaion. Solutions were exchanged every 30 min. The optimal length-
tension curve was not significantly different betwwn groups and calorimetric
cyanide was undetectable (< 0.2 @g/ml).Receptor-independent contraction
to KCI (6-60 mM) and reeeptor-dependent contraction to PGF~ (10-9–10-5
M) were aimilar between groups. Relaxations to calcium ionophore A23187
(10-9-10-6 M) wasattenuated in the 10”7 M and 10-5 M SNP groups but
not with 10-9 M SNP (n = 7 each, P <0.05, ANOVA). Relaxation to nitric
oxide (3 x 10-9-10-5 M) was markedly attenuated in the 10-7 M and 10-5
M SNP groupa but not with 10-9 M SNP (n = 7 each, P c 0.05). Relaxation
to nitric oxide was abolished with methylene blue pretreatment (10-5 M,
n = 4). Pretreatment with SNP did not alter vascular smooth muscie con-
tractions but markedly attenuated relaxation to both calcium ionophore and
authentic nitric oxide. These studies demonstrate desensitization of soluble
guanyiata cyclase in the intact coronav artety upon 3 hrexposure to SNP in
concentrations greater than 10-7 M.
D95842 Trestmentof lschemis-Repeffueion Demsge to theLstissimus Dorsi Muscle After Csrdiomyoplssty
Mobilization
V. Chekanov, V. Nikolaychik, G. Tchekanov, M. Rieder, D. Wankowski,
1.Hemandez, R. Eisenstein, P. Lelkes, D. Schmidt. Milwaukee Heart
Project, Milwaukee, WI, USA
Very often there are serious morphological changes in the Iatissimus dorai
muscle (LDM) used for csrdiomyopiasty (CMP) that mmpromise CMP re-
sults. These changes ars due to iechemia-repsrfusion damage affersubtotal
LDM mobilization. We hypothesized that application of an autologous bio-
logical glue (ABG) with pharmacological agenta (aprotinin, pyrrolostatin) to
the LDM would prevent ischemia-reperfusion damage, as well as increase
capillary ingrowth which would accelerate future angiogenesis.
Poeketawerecreated of ischemicand noniaohemicLDMtotestformuscle
damage and angiogenesie. One pocket was left free of ABG (control); one
received ABG only; one ABG with aprotinin; and one ABG with pyrrolostatin.
ABG was prepared from each animal’s citrated blood. Biopsies were taken
on days O,14,28 and 58.
Fibrosis, calcified neerosis, fiber degeneration, and leukocyte marination
were less in pockets with ABG than in the control pocket. The peak of these
changes waa noted on day 28 in the control pocket. No strong adhesions
between the ischemic LDM and adipose tissue wera noted in control pockets,
but were aeen in pockets with ABG.
In nonischemic LDM, capillaries oceupiad 4.0 + 0.24% of the area. The
results of the percent capillary area from the poeketa are below:
Control ABG ABG + Aprotinin ABG + Pyrrolostatin
Day 14 3.0* 0.9 4,1 * 0.4 5.2+ 2.1 7.9 * 1.9
Day 5S 3.s l 0.7 5,5l 0.2 S.5+ 1.1 9.4 * 1.9
E!31Suppression of Atherosclerotic Development in... . . . .Wstensbe Heritable Hyperlipidemic (WHHL)
Rabbits Treated with an Orai Anti-aliergic Drug,
Traniiast
T. Matsumura, K. Kugiyama, M. Ohgushi, S. Sugiyama, Y. Ohta, H. Doi,
H. Yasue. Kumamoto Universi~, Kumamoto, Japan
The atherosclerotic plaque beam many similarities to chronic inflammato~
conditions, and interactions between cellular components within the arterial
wall are considered to be easential in the progression of atherosclerotic
lesions. Tranilast, which is clinically used as an anti-allergic drug in Japan,
has been reported to be effective against the thickening of the intima after
endotheiial injuty by suppression of cell-mediated inflammato~ response. We
thus investigatedthe effects of tranilast on the development of atherosclerotic
changes in WHHL rabbits. WHHL rabbits (2 month old) were orally given
either 300 mglkg/day of the tranilast (Tranilast, n = 10) or vehicle (Vehicle,
n = 12) for 8 months. Tranilast-treatment suppressed percent aortic area
covered with plaque (Tranilast 39 + 5% va Vehicle 78 + 8%, p < 0.01) and
decreased contents of cholesterol and cholesterol esters in tha aortas. Little
difference was found in serum cholesterol levels between the 2 groups. The
cellular composition and phenotype of atherosclerotic plaques were analyzed
in immunohistochemical atudy.There was no difference in the percentage of
the RAM1l-posltlve microphage area in intimal plaques between Tranilast
and VehicJe.Most of the MHC claas II antigen (recognized as foreign by
T cells) -positive cells were macrophages, and the ratio of MHC class II
antigen-positive area to RAM1l-poaitive microphage area was markedly
lower in Tranilast as compared with that in Vehicle (Tranilast 18 + 7%
vs Vehicle 58 + 12%, p < 0.01). Furthermore, there was no difference
in the number of T cells between the two groups, but the percentages of
lnterleukin-2 (IL-2) receptor (CD25) positive cells (activated T cells) to pan
T cella was lower in Tranilast as compared with that in Vehicle, In an in
vitro study, the incubation of human peripheral bled mononuclear cells with
tranilast inhibitad the expression of MHC Class II antigen on monoeytea and
IL-2 receptors on T cells activated with IFN-y and IL-2, respectively. The
results indicated that tranilaat suppressed the atherosclerotic development
by downregulating the immune activation in atheromatous plaque.
m LOn~-term~iia~Prii TheraPYLimitsLefl
Ventricular Diastolic Dysfunction with Depressed
Systolic Function in Myocardiai Infarcted Rats
Y.Takemoto, M. Yoshiyama, K, Takeuchi, T. Shimada, K. Akioka,
M. Teragaki,J. Yoshikawa. First Depanment ofkrterna/ Medicine, Osaka
City University Medical School. Osaka, Japan
The purposes of this study were toasaessthe effeclof angiotensin mnverting
enzyme inhibitor (ACEI), cilazapril (1 m@kg/day) on left ventricular diaetolic
dyafunetionwith systoiicdysfunetion in myocardial infarcted (Ml) rats by using
echoeardiography and to analyze cardiac gene expression by northern blot
analysis. ACEI wea administered after Ml. On 1 and 3 months (M) after Ml,
left ventricular funciion were measured and mRNAs in cardiac tiseue were
analyzed. LV end-diastolic dimension (LVDd) and ejeclion fraction (EF) on 1
M were 9.7+ 0.5 mm and 34+ 4Y0,respectively,and LVDd on 3 M increased
to 10.4 + 0.3 and EF decreaaed to 30 + 6%. ACEI prevented an increase
of LVEDV (8.2 + 0.3 mm; p < 0.01) and improved FS (45 + 8%; p < 0.05)
on 1 M and also on 3 M. WA velocity ratio (E/A) and E wave deceleration
(E deee.) increased to 9.5+ 2.2 and 26.3+ 2.6 mkz on 1 M after Ml. ACEI
prevented the increase of E/A (4.2+ 0.5; P < 0/05) and E dece. (26.3+ 2.8
mkz; P c 0.05) on 1 M after Ml, and those on 3 M after Ml. The left and
right ventricular weight significantly increased after Ml, which were pravented
by ACEI. The gene expressions of j+myosin heavy chain (MHC), u-skeletal
aetin, atrial natriuretic peptide (ANP), collagen 1,Ill, in the nonischemic left
ventricular myoeardium increased by 1.8-, 2.9-, 4.2-, 3.0-, 2.6-fold on 1 M,
respecfivaly (p c 0.01) and RValso increased. ACEI significantly suppressed
theae increased gene expreaaions of nonischemic LV and RV. On contrary,
SR Ca-ATPase in nonischemic and RV decreased to 0.7- and 0.5- foid,
respectively,on 3 M after Ml and ACEI prevented them. In conclusion, ACEI
prevented the change of the properties of the myocardium and progressive
diaetolic and syetolic dysfunction by left ventricular remodeling after Ml.
Cone/usiorr.’ABGwith pharmacological agents can accelerate the healing
process and angiogenesis, and provide an organic bridge belween the LDM
and the myocardium after cardiomyoplasty.
